Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: Comparisons on long-term quality of life and symptom burden

BJU International

Volumn 105, Issue 5, 2010, Pages 652-658

  Thong, Melissa S Y ^a   Mols, Floortje ^a,b   Kil, Paul J M ^c   Korfage, Ida J ^d   Van De Poll Franse, Lonneke V ^a,b  

^a The Netherlands   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Active surveillance; Disease progression; External beam radiotherapy; Health related quality of life; Prostate cancer

Indexed keywords

ACTIVE SURVEILLANCE; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVOR; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PAIN; PALLIATIVE THERAPY; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RELIGION; SHORT FORM 36; WELLBEING;

AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RECTAL DISEASES; RECTUM; SURVIVORS; URINARY BLADDER; URINARY BLADDER DISEASES;

EID: 77149140107     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08815.x     Document Type: Article

References (32)

1. Dall'Era MA, Cooperberg MR, Chan JM et al. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer 2008 112 : 1650 1659
2. Schroder FH, Hugosson J, Roobol MJ et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009 360 : 1320 1328
3. Zerbib M, Zelefsky MJ, Higano CS, Carroll PR. Conventional treatments of localized prostate cancer. Urology 2008 72 (Suppl. S25 35
4. Klotz L. Active surveillance for favorable risk prostate cancer: rationale, risks, and results. Urol Oncol 2007 25 : 505 509 (Pubitemid 350151905)
5. Fransson P, Damber JE, Tomic R, Modig H, Nyberg G, Widmark A. Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer 2001 92 : 3111 3119
6. Pickles T, Ruether JD, Weir L, Carlson L, Jakulj F. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int 2007 100 : 544 551
7. Dall'Era MA, Konety BR, Cowan JE et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 2008 112 : 2664 2670
8. Bisson JI, Chubb HL, Bennett S, Mason M, Jones D, Kynaston H. The prevalence and predictors of psychological distress in patients with early localized prostate cancer. BJU Int 2002 90 : 56 61
9. Hedestig O, Sandman PO, Widmark A. Living with untreated localized prostate cancer: a qualitative analysis of patient narratives. Cancer Nurs 2003 26 : 55 60
10. Bailey DE Jr, Wallace M, Mishel MH. Watching, waiting and uncertainty in prostate cancer. J Clin Nurs 2007 16 : 734 741
11. Latini DM, Hart SL, Knight SJ et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol 2007 178 : 826 831
12. Burnet KL, Parker C, Dearnaley D, Brewin CR, Watson M. Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int 2007 100 : 540 543
13. Janssen-Heijnen MLG, Louwman WJ, Van de Poll-Franse LV, Coebergh JWW. Results of 50 Years Cancer Registry in the South of the Netherlands: 1955-2004 (in Dutch). Eindhoven : Eindhoven Cancer Registry, 2005
14. Mols F, van de Poll-Franse LV, Vingerhoets AJ et al. Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer 2006 107 : 2186 2196
15. Mols F, Korfage IJ, Vingerhoets AJ et al. Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population-based study. Int J Radiat Oncol Biol Phys 2008 73 : 30 8
16. van den Bergh RC, Roemeling S, Roobol MJ et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 2009 55 : 1 8
17. Soloway MS, Soloway CT, Williams S, Ayyathurai R, Kava B, Manoharan M. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 2008 101 : 165 169
18. Aaronson NK, Muller M, Cohen PD et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998 51 : 1055 1068
19. Ware J Jr. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA : The Health Institute, New England Medical Center, 1993
20. Norman GR, Sridhar FG, Guyatt GH, Walter SD. Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 2001 39 : 1039 1047
21. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003 41 : 582 592
22. van Dis FW, Mols F, Vingerhoets AJ, Ferrell B, van de Poll-Franse LV. A validation study of the Dutch version of the Quality of Life-Cancer Survivor (QOL-CS) questionnaire in a group of prostate cancer survivors. Qual Life Res 2006 15 : 1607 1612
23. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000 56 : 899 905
24. Korfage IJ, Essink-Bot ML, Madalinska JB, Kirkels WJ, Litwin MS, de Koning HJ. Measuring disease specific quality of life in localized prostate cancer: the Dutch experience. Qual Life Res 2003 12 : 459 464
25. UICC. TNM Atlas Illustrated Guide to the TNM/Ptnm Classification of Malignant Tumors, 4th edn. 2nd Revision. Berlin : Springer-Verlag, 1992 : 141 144
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40 : 373 383
27. Korfage IJ, Roobol M, de Koning HJ, Kirkels WJ, Schroder FH, Essink-Bot ML. Does 'normal' aging imply urinary, bowel, and erectile dysfunction? A general population survey. Urology 2008 72 : 3 9
28. Steineck G, Helgesen F, Adolfsson J et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002 347 : 790 796
29. van Tol-Geerdink JJ, Stalmeier PF, van Lin EN et al. Do patients with localized prostate cancer treatment really want more aggressive treatment? J Clin Oncol 2006 24 : 4581 4586
30. Hu JC, Kwan L, Krupski TL et al. Determinants of treatment regret in low-income, uninsured men with prostate cancer. Urology 2008 72 : 1274 1279
31. Crawford ED, Bennett CL, Stone NN et al. Comparison of perspectives on prostate cancer: analyses of survey data. Urology 1997 50 : 366 372
32. Stalmeier PF, van Tol-Geerdink JJ, van Lin EN et al. Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy. J Clin Oncol 2007 25 : 3096 3100